The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2, open-label study evaluating the efficacy, safety, and pharmacokinetics of luveltamab tazevibulin in infants and children CBFA2T3::GLIS2 acute myeloid leukemia.
 
Sarah Tasian
Honoraria - AstraZeneca; WUGEN, Inc.
Consulting or Advisory Role - Aleta Biotherapeutics; Jazz Pharmaceuticals; Syndax
Research Funding - Incyte; Kura Oncology
Travel, Accommodations, Expenses - Amgen; Jazz Pharmaceuticals
 
Himalee Sabnis
Research Funding - Bristol-Myers Squibb
 
Todd Cooper
Employment - Day One Biopharmaceuticals (I)
 
Francisco José Bautista Sirvent
No Relationships to Disclose
 
Arnaud Petit
No Relationships to Disclose
 
Matthew Kutny
No Relationships to Disclose
 
Elizabeth Krieger
No Relationships to Disclose
 
Laura Schuettpelz
No Relationships to Disclose
 
AeRang Kim
Research Funding - Ascentage Pharma (Inst); AstraZeneca Rare Disease (Inst); Jazz Pharmaceuticals (Inst); Valent Technologies (Inst)
 
Anne Borgman
Employment - Sutro Biopharma
Leadership - Curis; NextCure; NiKang Therapeutics
Stock and Other Ownership Interests - Curis; NextCure; NiKang Therapeutics
 
Stan Frankel
Consulting or Advisory Role - Sutro Biopharma
 
Anna Butturini
Employment - AstraZeneca; Sutro Biopharma
Stock and Other Ownership Interests - AstraZeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca; Sutro Biopharma
 
Lin Lu
Employment - Sutro Biopharma
 
Kate Murray
Employment - Sutro Biopharma
 
C. Michel Zwaan
No Relationships to Disclose